Amundi Has $59.95 Million Stake in Molina Healthcare, Inc $MOH

Key Points

• Amundi increased its Molina Healthcare stake by 41.9% in the second quarter, bringing its holdings to 262,111 shares valued at approximately $59.95 million. Institutional investors and hedge funds collectively own 98.5% of MOH.
• Analysts maintain a predominantly cautious outlook: 12 rate the stock “Hold,” compared with three “Buy” and two “Sell” ratings. The consensus price target is $202.44.
• Molina reported quarterly EPS of $1.51, beating estimates of $1.39, while revenue of $10.87 billion slightly exceeded forecasts. However, revenue declined 4.8% year over year, and the company posted a negative net margin.

Amundi raised its stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 41.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 262,111 shares of the company's stock after purchasing an additional 77,346 shares during the period. Amundi owned 0.50% of Molina Healthcare worth $59,945,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MOH. California State Teachers Retirement System lifted its stake in shares of Molina Healthcare by 23,008.3% in the second quarter. California State Teachers Retirement System now owns 13,816,682 shares of the company's stock worth $3,159,875,000 after acquiring an additional 13,756,891 shares during the period. BlackRock Inc. acquired a new stake in shares of Molina Healthcare during the second quarter worth $1,503,052,000. AQR Capital Management LLC increased its position in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock worth $561,475,000 after buying an additional 2,008,458 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company's stock worth $376,831,000 after buying an additional 201,772 shares during the last quarter. Finally, Invesco Ltd. raised its stake in Molina Healthcare by 24.2% during the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company's stock worth $293,453,000 after buying an additional 329,679 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of research analyst reports. Royal Bank Of Canada cut their price target on shares of Molina Healthcare from $248.00 to $218.00 and set a "sector perform" rating on the stock in a research report on Friday, July 24th. JPMorgan Chase & Co. lifted their price objective on Molina Healthcare from $169.00 to $191.00 and gave the stock a "neutral" rating in a research report on Monday, June 8th. Jefferies Financial Group set a $230.00 price objective on Molina Healthcare in a research note on Tuesday, July 14th. Mizuho set a $215.00 target price on Molina Healthcare in a research report on Monday, June 8th. Finally, TD Cowen raised their target price on Molina Healthcare from $163.00 to $230.00 and gave the stock a "hold" rating in a research note on Tuesday, July 14th. Three equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $202.44.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $200.49 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The stock's 50 day moving average is $208.26 and its 200-day moving average is $184.07. The firm has a market capitalization of $10.47 billion, a price-to-earnings ratio of -1,113.77, a PEG ratio of 27.82 and a beta of 0.75.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.12. The business had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. Molina Healthcare's quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.48 EPS. Sell-side analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company that provides health insurance and related services through government-sponsored programs. Its primary lines of business include Medicaid, Medicare, and Affordable Care Act Marketplace plans, with a focus on serving low-income individuals, families, seniors, and people with complex medical needs.

The company offers health plans that coordinate medical, behavioral health, pharmacy, and other care services through contracted provider networks.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.